GINA GUSTAFSON: Open Payments
NPI 1700511193 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 17 payments from 6 companies in 2025. Trend: 2023 $1,391 · 2024 $1,064 · 2025 $507
Food & beverage: $396Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $144 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| E.R. Squibb & Sons, L.L.C. | 9 | $140 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $19 |
Products named: Auvelity, COBENFY, FANAPT, AUSTEDO XR, ABILIFY MAINTENA, VIVITROL.
Industry payments across IN — which companies pay providers there.
